Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 200

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 200
---
 or regulation, any law or regulation respecting financial institutions or insurance      
 companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty 
 or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire    
 fraud or fraud in connection with any business entity; or                                                                               |

| ● | been the subject of, or                                                                                                             
 a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined 
 in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or  
 any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated 
 with a member.                                                                                                                      |

2022 Equity Incentive Plan On November 22, 2022, the Board and majority stockholder adopted the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the “Plan”). The Plan provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) nonstatutory stock options, (iii) stock appreciation rights, (iv) restricted stock awards, (v) restricted stock unit awards and (vi) other stock awards. The Plan is intended to help us secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for our success and any of our affiliates and provide a means by which the eligible recipients may benefit from increases in value of the common stock. As of February 14, 2025, the Board has reserved 1,077,252 shares of common stock issuable upon the grant of awards under the Plan, of which 285,373 shares remain available for issuance. 119 EXECUTIVE COMPENSATION

| Name and Principal Position                  |     | Year |     | Base   
 Salary 
 ($)(1) |          |     | Cash Bonus 
 ($)        |         |     | Stock 
 Bonus 
 ($)   |        |     | Option 
 Award  
 ($)(2) |        |     | Total 
 ($)   |         |
|:---------------------------------------------|:----|-----:|:----|:-------|---------:|:----|:-----------|--------:|:----|:------|-------:|:----|:-------|-------:|:----|: